Skip to main content

Specific PFAS Differentially Affect Maternal Midlife Adiposity

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 9, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 9, 2024 -- Specific perfluoroalkyl and polyfluoroalkyl substances (PFAS) measured in early pregnancy differentially affect maternal midlife adiposity, according to a study published online Sept. 5 in the Journal of Clinical Endocrinology & Metabolism.

Jordan A. Burdeau, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated associations of early pregnancy measures of individual PFAS and PFAS mixtures with maternal adiposity in midlife in 547 Project Viva participants.

The researchers found that per doubling of perfluorooctane sulfonate (PFOS) and 2-(N-ethyl-perfluorooctane sulfonamido) acetate, linear regression estimated higher midlife weight (3.8 and 2.3 kg, respectively). A positive association was seen between PFOS and midlife adiposity (weight, 7.7 kg), trunk fat mass (1.2 kg), and total body fat mass (3.0 kg) in Bayesian Kernel Machine Regression; inverse associations were seen for perfluorononanoate and perfluorohexane sulfonate. For the overall PFAS mixture, no associations were seen.

"If our findings are supported by additional evidence, we may improve understanding of the effects of PFAS on cardiometabolic health during pregnancy, which in turn may improve early prevention or detection of adverse cardiometabolic health outcomes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...

USPSTF Recommends Counseling to Prevent Perinatal Depression

FRIDAY, April 25, 2025 -- The U.S. Preventive Services Task Force (USPSTF) recommends counseling for women at increased risk for perinatal depression (PND). This recommendation...

More Than 3.6 Million Births Recorded in the United States in 2024, Up 1 Percent From 2023

WEDNESDAY, April 23, 2025 -- In 2024, the provisional number of births in the United States was 3,622,673, which was 1 percent higher than in 2023, according to an April Vital...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.